177 related articles for article (PubMed ID: 8622104)
1. Isepamicin versus amikacin in the treatment of urinary tract infection.
Sturm W
J Chemother; 1995 Jun; 7 Suppl 2():149-54. PubMed ID: 8622104
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
Covi M; Velluti G
J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.
Rodriguez-Noriega E; Esparza-Ahumada S; Morfin-Otero R
J Chemother; 1995 Jun; 7 Suppl 2():155-60. PubMed ID: 8622105
[TBL] [Abstract][Full Text] [Related]
4. Once daily isepamicin treatment in complicated urinary tract infections.
Lee SS; Liu YC; Wann SR; Lin WR; Tsai TH; Lin HH; Chen YS; Yen MY
J Microbiol Immunol Infect; 1999 Jun; 32(2):105-10. PubMed ID: 11561574
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
Colardyn F
J Chemother; 1995 Jun; 7 Suppl 2():129-35. PubMed ID: 8622101
[TBL] [Abstract][Full Text] [Related]
6. Overview of the efficacy of isepamicin in the adult core clinical trial programme.
Carbon C
J Chemother; 1995 Jun; 7 Suppl 2():79-85. PubMed ID: 8622115
[TBL] [Abstract][Full Text] [Related]
7. An overview of the safety of isepamicin in adults.
Blum D
J Chemother; 1995 Jun; 7 Suppl 2():87-93. PubMed ID: 8622116
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia.
Beaucaire G
J Chemother; 1995 Jun; 7 Suppl 2():165-73. PubMed ID: 8622107
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of isepamicin compared with amikacin in the treatment of intra-abdominal infections.
Leal del Rosal P
J Chemother; 1995 Jun; 7 Suppl 2():143-8. PubMed ID: 8622103
[TBL] [Abstract][Full Text] [Related]
10. A randomised comparison of isepamicin and amikacin in the treatment of bacterial infections in paediatric patients.
Viganò A; Principi N
J Chemother; 1995 Jun; 7 Suppl 2():95-101. PubMed ID: 8622117
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy and safety of isepamicin in the treatment of various bacterial infections.
Petrikkos G; Giamarellou H; Tsagaraki C; Pefanis A
J Chemother; 1995 Jun; 7 Suppl 2():161-4. PubMed ID: 8622106
[TBL] [Abstract][Full Text] [Related]
12. Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
Herbrecht R; Blaise D; Espinouse D; Leblond V; Sadoun A; Sauvage C; Cordonnier C; Minozzi C
J Chemother; 1995 Jun; 7 Suppl 2():103-10. PubMed ID: 8622099
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
[TBL] [Abstract][Full Text] [Related]
14. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
Leonard JM; McGee ZA; Alford RH
Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
[TBL] [Abstract][Full Text] [Related]
15. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized study of once-daily versus twice-daily amikacin regimens in patients with systemic infections.
Karachalios GN; Houpas P; Tziviskou E; Papalimneou V; Georgiou A; Karachaliou I; Halkiadaki D
Int J Clin Pharmacol Ther; 1998 Oct; 36(10):561-4. PubMed ID: 9799062
[TBL] [Abstract][Full Text] [Related]
17. [Amikacin in urinary tract infections with so-called problem pathogens].
Hofstetter A; Staehler G
Fortschr Med; 1976 Aug; 94(24):1305-8. PubMed ID: 786834
[TBL] [Abstract][Full Text] [Related]
18. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
Wells WG; Woods GL; Jiang Q; Gesser RM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
[TBL] [Abstract][Full Text] [Related]
19. Isepamicin versus amikacin for the treatment of acute pyelonephritis in children.
Kafetzis DA; Maltezou HC; Mavrikou M; Siafas C; Paraskakis I; Delis D; Bartsokas C
Int J Antimicrob Agents; 2000 Feb; 14(1):51-5. PubMed ID: 10717501
[TBL] [Abstract][Full Text] [Related]
20. Netilmicin treatment of complicated urinary tract infections.
Madsen PO; Baumueller A; Frimodt-Møller N; Hoyme U; Lau C; Maigaard S; Nielsen OS; Welling PG
Scand J Infect Dis Suppl; 1980; Suppl 23():128-31. PubMed ID: 6937956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
